Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Maraviroc and Boosted Atazanavir Dual Regimen in Stable HIV-infected Patients

NCT03708861 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT03708861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03708861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Maraviroc and Boosted Atazanavir Dual Regimen in Stable HIV-infected Patients
Lead sponsor
University of Turin, Italy
Phase
Phase 3
Overall status
Withdrawn
Start date
January 31, 2016
Completion date
December 31, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection